Scientific Papers

Tumor seeding following CT- guided transthoracic needle biopsy in lung cancer. A case report | BMC Pulmonary Medicine


  • World Health Organization. Key facts, cancer. www.who.int. Published online. February. 3rd, 2022. [cited December 4th 2022] www.who.int/news-room/fact-sheets/detail/cancer.

  • Chen X, Mo S, Yi B. The spatiotemporal dynamics of Lung cancer: 30-year trends of epidemiology across 204 countries and territories. BMC Public Health. 2022;22:987. https://doi.org/10.1186/s12889-022-13281-y.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Miller M, Hanna N. Advances in systemic therapy for non-small cell Lung cancer BMJ 2021; 375:n2363 https://doi.org/10.1136/bmj.n2363.

  • National Cancer Institute. www.seer.cancer.gov. Published online 2022. [Cited January 1st 2023] https://seer.cancer.gov/statfacts/html/lungb.html.

  • Ru Zhao Y, Xie X, de Koning HJ, Mali WP, Vliegenthart R, Oudkerk M. NELSON lung cancer screening study. Cancer Imaging. 2011;11 Spec No A(1A):S79-84. https://doi.org/10.1102/1470-7330.2011.9020. PMID: 22185865; PMCID: PMC3266562.

  • US Preventive Services Task Force. Screening for Lung Cancer: US Preventive Services Task Force Recommendation Statement. JAMA. 2021;325(10):962–70. https://doi.org/10.1001/jama.2021.1117.

    Article 

    Google Scholar
     

  • Lung Cancer Canada. Lung Cancer Screening in Canada. www.lungcancercanada.ca. Published online. 2022. [Cited January 1st 2023] https://www.lungcancercanada.ca/en-CA/Lung-Cancer/Screening.aspx#Recomendations.

  • Gemeinsamer Bundesausschuss der Ärzte und Krankenkassen. Screening auf Lungenkrebs: G-BA leitet Beratungsverfahren erst mit Rechtsverordnung einwww.g-ba.de. Published online. April 30th 2021. [cited January 1st 2023] https://www.g-ba.de/presse/pressemitteilungen-meldungen/953/.

  • Passiglia F, Cinquini M, Bertolaccini L, Del Re M, Facchinetti F, Ferrara R, Franchina T, Larici AR, Malapelle U, Menis J, Passaro A, Pilotto S, Ramella S, Rossi G, Trisolini R, Novello S. Benefits and Harms of Lung Cancer Screening by Chest Computed Tomography: A Systematic Review and Meta-Analysis. J Clin Oncol. 2021;39(23):2574–2585. https://doi.org/10.1200/JCO.20.02574. Epub 2021 Jun 2. Erratum in: J Clin Oncol. 2021;39(28):3192–3193. PMID: 34236916.

  • Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft., Deutsche Krebshilfe,AWMF): Prävention, Diagnostik, Therapie und Nachsorge des Lungenkarzinoms, Langversion 2.1, Published online 2022. AWMF-Registernummer: 020/007OL, [cited December 4th 2022] https://www.leitlinienprogramm-onkologie.de/leitlinien/ lungenkarzinom.

  • Ahn SY, Yoon SH, Yang BR, Kim YT, Park CM, Goo JM. Risk of pleural recurrence after percutaneous transthoracic needle biopsy in stage I non-small-cell Lung cancer. Eur Radiol. 2019;29(1):270–8. https://doi.org/10.1007/s00330-018-5561-5. Epub 2018 Jun 15. PMID: 29948086.

    Article 
    PubMed 

    Google Scholar
     

  • Sano Y, Date H, Toyooka S, Oto T, Yamane M, Hiraki T, Gobara H, Mimura H, Kanazawa S. Percutaneous computed tomography-guided lung biopsy and pleural dissemination: an assessment by intraoperative pleural lavage cytology. Cancer. 2009;115(23):5526-33. https://doi.org/10.1002/cncr.24620. PMID: 19685526.

  • Kim JH, Kim YT, Lim HK, Kim YH, Sung SW. Management for chest wall implantation of non-small cell lung cancer after fine-needle aspiration biopsy. Eur J Cardiothorac Surg. 2003;23(5):828 – 32. https://doi.org/10.1016/s1010-7940(03)00095-2. PMID: 12754041.

  • Kim MG, Yang BR, Park CM, Yoon SH. Preoperative percutaneous needle lung biopsy techniques and ipsilateral pleural recurrence in stage I Lung cancer. Eur Radiol. 2022;32(4):2683–92. https://doi.org/10.1007/s00330-021-08359-x. Epub 2022 Jan 10. PMID: 35001158.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Hong H, Hahn S, Matsuguma H, Inoue M, Shintani Y, Honda O, Izumi Y, Asakura K, Asamura H, Isaka T, Lee K, Choi YS, Kim YT, Park CM, Goo JM, Yoon SH. Pleural recurrence after transthoracic needle lung biopsy in stage I Lung cancer: a systematic review and individual patient-level meta-analysis. Thorax. 2021;76(6):582–90. https://doi.org/10.1136/thoraxjnl-2020-216492. Epub 2021 Mar 15. PMID: 33723018.

    Article 
    PubMed 

    Google Scholar
     

  • Boutin C, Rey F, Viallat JR. Prevention of malignant seeding after invasive diagnostic procedures in patients with pleural mesothelioma. A randomized trial of local radiotherapy. Chest. 1995;108(3):754-8. https://doi.org/10.1378/chest.108.3.754. PMID: 7656629.

  • Popat S, Baas P, Faivre-Finn C, Girard N, Nicholson AG, Nowak AK, Opitz I, Scherpereel A, Reck M, ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org. Malignant pleural Mesothelioma: ESMO Clinical Practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2022;33(2):129–42. Epub 2021 Nov 30. PMID: 34861373.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Bayman N, Appel W, Ashcroft L, Baldwin DR, Bates A, Darlison L, Edwards JG, Ezhil V, Gilligan D, Hatton M, Jegannathen A, Mansy T, Peake MD, Pemberton L, Rintoul RC, Snee M, Ryder WD, Taylor P, Faivre-Finn C. Prophylactic irradiation of tracts in patients with malignant pleural Mesothelioma: an Open-Label, Multicenter, Phase III Randomized Trial. J Clin Oncol. 2019;37(14):1200–8. Epub 2019 Mar 28. PMID: 30920878.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Brierley JD, Asamura H, van Eycken E, Rous B. TNM Atlas, 7th edition. Union for International Cancer Control. Wiley, Hoboken, 2021&#8195.

  • Krebs in. Deutschland für 2017/2018. 13. Ausgabe. Robert Koch-Institut, Herausgeber und die Gesellschaft der epidemiologischen Krebsregister in Deutschland e.V, Herausgeber. Berlin, 2021.

  • Aramini B, Banchelli F, Bettelli S, Manfredini S, D’Amico R, Masciale V, Pinelli M, Moretti M, Stefani A, Bertolini F, Dominici M, Morandi U, Maiorana A. Overall survival in patients with lung adenocarcinoma harboring niche mutations: an observational study. Oncotarget. 2020;11(5):550–9. https://doi.org/10.18632/oncotarget.27472. PMID: 32082488; PMCID: PMC7007296.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Yoshikawa T, Yoshida J, Nishimura M, Yokose T, Nishiwaki Y, Nagai K. Lung cancer implantation in the chest wall following percutaneous fine needle aspiration biopsy. Jpn J Clin Oncol. 2000;30(10):450-2. https://doi.org/10.1093/jjco/hyd120. PMID: 11185892.

  • de Koning HJ, van der Aalst CM, de Jong PA, Scholten ET, Nackaerts K, Heuvelmans MA, Lammers JJ, Weenink C, Yousaf-Khan U, Horeweg N, van ‘t Westeinde S, Prokop M, Mali WP, Mohamed Hoesein FAA, van Ooijen PMA, Aerts JGJV, den Bakker MA, Thunnissen E, Verschakelen J, Vliegenthart R, Walter JE, Ten Haaf K, Groen HJM, Oudkerk M. Reduced Lung-Cancer mortality with volume CT screening in a Randomized Trial. N Engl J Med. 2020;382(6):503–13. https://doi.org/10.1056/NEJMoa1911793. Epub 2020 Jan 29. PMID: 31995683.

    Article 
    PubMed 

    Google Scholar
     

  • Li H, Chen R, Zhao J. Correlation between percutaneous transthoracic needle biopsy and recurrence in stage I Lung cancer: a systematic review and meta-analysis. BMC Pulm Med. 2020;20(1):198. https://doi.org/10.1186/s12890-020-01235-2. PMID: 32689974; PMCID: PMC7372860.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Asakura K, Izumi Y, Yamauchi Y, Nakatsuka S, Inoue M, Yashiro H, Abe T, Sato Y, Nomori H. Incidence of pleural recurrence after computed tomography-guided needle biopsy in stage I Lung cancer. PLoS ONE. 2012;7(8):e42043. https://doi.org/10.1371/journal.pone.0042043. Epub 2012 Aug 2. PMID: 22876299; PMCID: PMC3410895.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Moon SM, Lee DG, Hwang NY, Ahn S, Lee H, Jeong BH, Choi YS, Shim YM, Kim TJ, Lee KS, Kim H, Kwon OJ, Lee KJ. Ipsilateral pleural recurrence after diagnostic transthoracic needle biopsy in pathological stage I Lung cancer patients who underwent curative resection. Lung Cancer. 2017;111:69–74. Epub 2017 Jul 12. PMID: 28838402.

    Article 
    PubMed 

    Google Scholar
     

  • Cheng Y, Zhang T, Xu Q. Therapeutic advances in non-small cell lung cancer: Focus on clinical development of targeted therapy and immunotherapy. MedComm (2020). 2021;2(4):692–729. https://doi.org/10.1002/mco2.105. PMID: 34977873; PMCID: PMC8706764.



  • Source link